NAPATREE CAPITAL LLC quarter change: Foreign Stocks, Reduced
In share positions in stocks (depositary receipts and foreign shares traded over the counter), from the quarter ended 2024-12-31 to 2025-03-31, NAPATREE CAPITAL LLC opened 0 positions, added to 0, reduced 2, sold out of 0 and left 0 unchanged. The largest increase in value was GSK (+$8,519); the largest decrease was OPRA (-$90,166).
- OPRA: Country of operation —; Class SPONSORED ADS; Shares 2024-12-31 26,777; Shares 2025-03-31 26,160.
- GSK: Country of operation —; Class SPONSORED ADR; Shares 2024-12-31 11,519; Shares 2025-03-31 10,276.
Two Form 13F-HR filings compared (SEC CIK 2015964): 2024-12-31 (filed 2025-02-11) and 2025-03-31 (filed 2025-05-02). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||